Systematix Shares strategy head says that earnings estimates are starting to be revised on the downside, interest costs are rising, and profits are declining. In fact, profits have also contracted both at the operating profit levels and also at the net profit level. There may be more corrections going ahead. It is better for investors wait before buying into any diagnostic stocks.